Jueqi Chen

2.5k total citations · 3 hit papers
9 papers, 2.0k citations indexed

About

Jueqi Chen is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jueqi Chen has authored 9 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Jueqi Chen's work include interferon and immune responses (5 papers), NF-κB Signaling Pathways (3 papers) and Inflammasome and immune disorders (3 papers). Jueqi Chen is often cited by papers focused on interferon and immune responses (5 papers), NF-κB Signaling Pathways (3 papers) and Inflammasome and immune disorders (3 papers). Jueqi Chen collaborates with scholars based in United States. Jueqi Chen's co-authors include Zhijian J. Chen, Lijun Sun, Siqi Liu, Xin Cai, Xiaojun Tan, Hui Xu, Randal Halfmann, Qiu‐Xing Jiang, Jiaxi Wu and Xiang Chen and has published in prestigious journals such as Nature, Cell and Nature Communications.

In The Last Decade

Jueqi Chen

9 papers receiving 2.0k citations

Hit Papers

PtdIns4P on dispersed trans-Golgi network mediates NLRP3 ... 2014 2026 2018 2022 2018 2014 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jueqi Chen United States 7 1.4k 1.2k 300 217 183 9 2.0k
John D. Lich United States 19 1.7k 1.2× 1.6k 1.3× 240 0.8× 244 1.1× 122 0.7× 25 2.5k
Chun Kim South Korea 19 1.5k 1.0× 935 0.8× 326 1.1× 237 1.1× 102 0.6× 36 2.1k
Monika Schneider United States 11 1.4k 1.0× 1.5k 1.2× 205 0.7× 177 0.8× 187 1.0× 14 2.1k
Fiachra Humphries United States 15 1.0k 0.7× 770 0.6× 162 0.5× 141 0.6× 222 1.2× 32 1.6k
Hiroto Kambara United States 18 1.1k 0.8× 852 0.7× 277 0.9× 326 1.5× 247 1.3× 26 2.0k
Chris B. Moore United States 16 2.0k 1.4× 1.8k 1.5× 257 0.9× 594 2.7× 283 1.5× 20 3.1k
Jonathan A. Harton United States 24 1.0k 0.7× 1.1k 0.9× 123 0.4× 112 0.5× 112 0.6× 44 1.7k
Moritz M. Gaidt Germany 17 2.0k 1.4× 1.7k 1.4× 108 0.4× 298 1.4× 404 2.2× 22 2.8k
Hiroaki Shime Japan 25 651 0.5× 1.2k 1.0× 251 0.8× 194 0.9× 99 0.5× 47 1.9k
Jenny Pan-Yun Ting United States 15 1.1k 0.7× 1.1k 0.9× 95 0.3× 159 0.7× 94 0.5× 16 1.8k

Countries citing papers authored by Jueqi Chen

Since Specialization
Citations

This map shows the geographic impact of Jueqi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jueqi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jueqi Chen more than expected).

Fields of papers citing papers by Jueqi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jueqi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jueqi Chen. The network helps show where Jueqi Chen may publish in the future.

Co-authorship network of co-authors of Jueqi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jueqi Chen. A scholar is included among the top collaborators of Jueqi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jueqi Chen. Jueqi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ye, Chengjin, et al.. (2025). SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity. Nature Communications. 16(1). 4393–4393. 1 indexed citations
2.
Xiao, Nanyang, et al.. (2025). Type A cholesterol-dependent cytolysins translocate to the trans-Golgi network for NLRP3 inflammasome activation. Nature Immunology. 26(10). 1673–1685. 1 indexed citations
3.
Chen, Jueqi, et al.. (2020). NLRP9 in innate immunity and inflammation. Immunology. 162(3). 262–267. 22 indexed citations
4.
Chen, Jueqi & Zhijian J. Chen. (2018). PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 564(7734). 71–76. 508 indexed citations breakdown →
5.
Tan, Xiaojun, Lijun Sun, Jueqi Chen, & Zhijian J. Chen. (2018). Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids. Annual Review of Microbiology. 72(1). 447–478. 334 indexed citations breakdown →
6.
Cai, Xin, Jueqi Chen, Hui Xu, et al.. (2014). Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation. Cell. 156(6). 1207–1222. 464 indexed citations breakdown →
7.
Chen, Jueqi & Zhijian J. Chen. (2013). Regulation of NF-κB by ubiquitination. Current Opinion in Immunology. 25(1). 4–12. 215 indexed citations
8.
Liu, Siqi, Jueqi Chen, Xin Cai, et al.. (2013). MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife. 2. e00785–e00785. 300 indexed citations
9.
Skaug, Brian, Jueqi Chen, Fenghe Du, et al.. (2011). Direct, Noncatalytic Mechanism of IKK Inhibition by A20. Molecular Cell. 44(4). 559–571. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026